Plant Health Care PLC Saori Trial Update
March 01 2021 - 1:00AM
RNS Non-Regulatory
TIDMPHC
Plant Health Care PLC
01 March 2021
Reach
1 March 2021
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Saori Trial Update
Preliminary results for the Prevention and Treatment of Asian
Soybean Rust in Brazil
Plant Health Care(R) (AIM: PHC.L) , a leading provider of novel
patent-protected biological products to global agriculture markets,
provides an update on its most advanced proprietary soybean seed
treatment for the prevention and treatment of Asian Soybean Rust
("ASR").
Highlights
-- PHC279 has been named "Saori(TM)" for Brazil soybeans, to
build brand recognition in the marketplace
-- Sixteen field trials successfully completed
-- Saori consistently improved control of ASR
-- 6x RoI demonstrated for Brazilian soybean growers
-- Initial commercial discussions are under way with distributors
-- Commercial launch on track for the second half of 2021
Background
PHC279 is the Company's first product from its PREtec platform
to be commercialised. To aid brand recognition in the marketplace,
PHC279 has been named "Saori(TM)" for seed treatment in Brazil
soybeans.
Brazil is the world's leading soybean producer with more than 38
million hectares (95 million acres) planted in the current season.
ASR, caused by the fungus Phakopsora pachyrhizi, is a devastating
disease which can lead to crop yield loss of up to 90%. Brazilian
soybean farmers spent US$2.85 billion on disease control in the
2019/20 season, approximately 90% of which was for ASR control.
Saori is the first PREtec peptide approved in Brazil. PREtec
peptides represent a novel class of technology which stimulate the
plant to defend itself. Derived from natural proteins, PREtec is an
environmentally friendly approach to protecting crops and is
compatible with mainstream agricultural practices.
Testing Protocol
To date, the Company has completed 16 trials using commercial
volumes of Saori and has 34 trials ongoing this season. PHC and its
partners have been visiting the ongoing soybean trials across
Brazil. Preliminary results suggest significantly improved early
plant growth and enhanced early season disease control in the Saori
treated fields.
Preliminary Test Results
Across all 16 trials, Saori consistently improved control of
ASR. Saori shows potential as a novel tool for integrated pest
management systems, reducing the use of potentially less safe
agrochemicals during the trial period.
From a value proposition perspective, Saori demonstrated the
potential to deliver disease control and increased crop yield worth
an average of about US$85/ha for Brazilian soybean growers,
delivering a Return on Investment ("RoI") of 6x or more.
PHC has now begun commercial discussions with leading crop
protection companies in Brazil, many of which have planted their
own soybean trials to independently confirm the performance of
Saori.
The Company is planning the commercial launch of Saori during
the second half of 2021. Initial sales will specifically focus on
early adopters of novel technologies within the sustainable
agricultural markets. Significant penetration of a market estimated
to be worth approximately US$2.56bn per annum is expected over the
following three to five years.
Chris Richards, CEO of Plant Health Care said , " Saori has the
potential to be a truly disruptive and sustainable technology in
soybeans, boosting crop growth while improving disease control. It
is not only highly cost-effective, but also delivers a big step in
improving the sustainability of soybean production. While drought
delayed planting in many areas of Brazil, Saori is demonstrating
encouraging performance during the current soybean season; we are
already seeing increased vigour and early season disease control.
We look forward with confidence to the initial commercial launch of
Saori in the second half of 2021. Outside Brazil, we are preparing
to launch PREtec products to markets in the U.S. and other
countries, initially targeting markets with opportunities greater
than $5 billion."
For further information, please contact:
Plant Health Care plc
Chris Richards, CEO, Tel: +1 919 926 1600
Arden Partners plc - Nomad & Broker
John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900
Vox Markets - Digital investor relations
Paul Cornelius / Kat Perez Tel; +44 (0) 7866 384707
Company website: http://www.planthealthcare.com
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute non-regulatory news releases into
the public domain. Information required to be notified under the
AIM Rules for Companies, Market Abuse Regulation or other
regulation would be disseminated as an RNS regulatory announcement
and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRALQLLLFLLFBBE
(END) Dow Jones Newswires
March 01, 2021 02:00 ET (07:00 GMT)
Plant Health Care (LSE:PHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Plant Health Care (LSE:PHC)
Historical Stock Chart
From Apr 2023 to Apr 2024